FDA Approves Penpulimab for Nasopharyngeal Cancer

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal antibody.
Medscape Medical News